Use of blood based biomarkers in the evaluation of Crohn’s disease and ulcerative colitis
Edward L Barnes, Robert Burakoff, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, Boston, MA 02115, United States
Choong-Chin Liew, Golden Health Diagnostics, Inc., Toronto, Ontario M4N 3M5, Canada
Samuel Chao, GeneNews, Toronto, Ontario M4N 3M5, Canada
Author contributions: Barnes EL conceived the issues which formed the content of the manuscript and drafted the manuscript; Liew CC, Chao S, and Burakoff R conceived the issues which formed the contents of the manuscript and made critical revisions to the content of the manuscript; all authors approved the final version of this manuscript.
Supported by National Institutes of Health T32 Training Grant, No. T32 DK007533-29.
Conflict-of-interest statement: The authors have no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Edward L Barnes, MD, Research/Clinical Fellow in Gastroenterology, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, United States. firstname.lastname@example.org
Telephone: +1-617-7326389 Fax: +1-617-5660338
Received: June 16, 2015
Peer-review started: June 18, 2015
First decision: July 27, 2015
Revised: August 14, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: November 25, 2015